Conceivable Raises $50 Million to Bring Robotic IVF Embryo Lab to US
Conceivable Life Sciences, a company that develops robotic technology for in-vitro fertilization (IVF) embryo labs, has raised $50 million in funding. The company's goal is to bring its automated embryo-creation system to more IVF clinics in the United States, with plans to have it available by early next year. The robotic lab system is designed to streamline the IVF process by automating the creation and cultivation of human embryos. This technology aims to increase efficiency and consistency in IVF treatments, potentially improving outcomes for patients. The funding will be used to further develop and commercialize Conceivable's technology, making it more widely accessible to IVF clinics across the country. This investment reflects the growing interest and potential of robotic solutions in the field of reproductive healthcare.
Source: For the complete article, please visit the original source link below.
